精神健康成医药并购新风口!传艾伯维(ABBV.US)正洽谈收购Gilgamesh 估值或达10亿美元

智通财经
Jul 31
【精神健康成医药并购新风口!传艾伯维(ABBV.US)正洽谈收购Gilgamesh 估值或达10亿美元】智通财经APP获悉,据知情人士透露,艾伯维(ABBV.US)正在洽谈收购专注于精神健康治疗的Gilgamesh Pharmaceuticals。知情人士表示,这笔潜在交易会对未上市的Gilgamesh的估值可能达到约10亿美元。他们表示,相关公告可能会在未来几周内公布。知情人士补充称,谈判仍在进行中,仍有可能被推迟或最终破裂。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10